100
Participants
Start Date
August 28, 2023
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Buprenorphine/ Methadone exposure
Validate candidate genes- and prenatal opioid exposure- related maternal relapse and NOWS outcome associations in pregnant women and their newborns.
RECRUITING
UPMC Magee-Womens Hospital, Pittsburgh
National Institute on Drug Abuse (NIDA)
NIH
OpalGenix, Inc
INDUSTRY
Ilana Hull
OTHER